hat
Plizyè mekanis yo te pwopoze pou posib aktivite anticarcinogenic genistein. Men sa yo enkli upregulation nan apoptoz, anpèchman nan angiogenesis, anpèchman nan AD II topoisomerase ak anpèchman nan kinas tyrosine kinas. Lòt posib mekanism kansè anti-pwostat gen ladan anpèchman nan NF (nikleyè faktè) -kappa B nan selil kansè pwostat, downregulation nan TGF (transfòme kwasans faktè) -beta ak anpèchman EGF (epidèm faktè kwasans) - stimulé kwasans.
eng
Several mechanisms have been proposed for genistein's possible anticarcinogenic activity. These include upregulation of apoptosis, inhibition of angiogenesis, inhibition of DNA topoisomerase II and inhibition of protein tyrosine kinases. Other possible anti-prostate cancer mechanisms include inhibition of NF (nuclear factor)-kappa B in prostate cancer cells, downregulation of TGF (transforming growth factor)-beta and inhibition of EGF (epidermal growth factor)- stimulated growth.